Skip to content

Epidemiological Study of Inflammatory Myopathies in a French Region

Prevalence of Inflammatory Myopathies in Alsace

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02881450
Acronym
PREMIA
Enrollment
117
Registered
2016-08-29
Start date
2012-01-31
Completion date
2019-08-31
Last updated
2019-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polymyositis

Brief summary

Knowledge of the descriptive epidemiology of MIs is very limited. The main objective of this study is to determine the prevalence of inflammatory myopathies in Alsace at the 1st January 2012 with capture-recapture design using several independent sources of case identification.

Detailed description

Inflammatory myopathies (MIs) are a group of muscle diseases with a significant heterogeneity, clinical, immunological and prognosis. The old classifications, still currently used, highlight this heterogeneity. Therefore Troyanov and coll. and Hoogendijk and coll. have each recently proposed a classification based on clinical and serological - and immuno- histological examination. The pathogenesis and prognosis of MIs is very different depending on the entity in question. Knowledge of the descriptive epidemiology of MIs is very limited. In fact no epidemiological work using criteria consensual classification is actually started. We propose an epidemiological study of MIs. The main objective of the study is to determine the prevalence of MIs in Alsace at 1stJanuary 2012 by means of a capture- recapture study using several independent sources of case identification. The secondary objectives of the study are: * estimating the geographical distribution of the disease in the Alsace region and / or Auvergne * demographic description of patients : age, sex, residence , occupation * description of the disease: patient age at diagnosis, disease classification , main clinical manifestations and complications * Identification of paraneoplastic forms will be for the Alsace region by crossing with Alsatian cancer registries. These records will be interviewed to identify cases of MIs associated with cancers.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patient reported suffering from inflammatory myopathy * Meeting the Hoogendijk, Troyanov and Griggs classification criteria * Alive at 1st January 2012- Domiciled in Alsace (Bas-Rhin or Haut-Rhin counties of France)

Exclusion criteria

* All patient reported with a different or incomplete diagnosis of inflammatory myopathy (not meeting the Hoogendijk, Troyanov and Griggs criteria) * All patient dead and/or non-domiciled in Alsace at 1st January 2012

Design outcomes

Primary

MeasureTime frame
Estimate the prevalence of idiopathic inflammatory myopathies in Alsace.Prevalence of idiopathic inflammatory myopathies in Alsace at 1st January 2012

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026